Breaking News

Meggle Introduces Triple Compound CombiLac

Offers improved compaction properties in direct compression applications

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Meggle has launched the new high-functionality excipient (HFE) CombiLac, a lactose-based, co-processed excipient, specifically designed to ease oral solid dosage form development and manufacture in direct compression (DC). CombiLac, an innovative, co-processed HFE consists of the spray-dried, ternary admixture of alpha-lactose monohydrate, MCC and starch, each conforming with Ph. Eur., USP-NF, and JP compendial requirements. A well-defined manufacturing process generates porous, spherical par...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters